Protagonist Therapeutics Inc (PTGX)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 275,188 | -78,955 | -123,413 | -122,627 | -66,150 |
| Total assets | US$ in thousands | 744,725 | 357,951 | 247,928 | 347,695 | 324,468 |
| ROA | 36.95% | -22.06% | -49.78% | -35.27% | -20.39% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $275,188K ÷ $744,725K
= 36.95%
Protagonist Therapeutics Inc's Return on Assets (ROA) has exhibited significant volatility over the past five years.
- As of December 31, 2020, the ROA was at a low of -20.39%, indicating that the company generated a negative return relative to its total assets.
- The ROA deteriorated further by December 31, 2021, reaching -35.27%, implying a deeper negative return on assets.
- By December 31, 2022, the ROA plummeted to -49.78%, signaling a substantial decline in the company's ability to generate profits from its assets.
- Although there was a slight recovery by December 31, 2023, with the ROA at -22.06%, the company still struggled to achieve a positive return on its assets.
- The most notable improvement occurred by December 31, 2024, with the ROA reaching 36.95%, signifying a significant turnaround in the company's profitability and efficiency in generating returns from its assets.
Overall, Protagonist Therapeutics Inc's ROA has experienced fluctuations, with a mix of negative and positive returns over the years, culminating in a notable positive performance by the end of the period.
Peer comparison
Dec 31, 2024